The Optimization and Evaluation of Flibanserin Fast-Dissolving Oral Films

Flibanserin (FLB) is a drug used for female hypotensive sexual desire disorder approved by the FDA in August 2015. FLB exhibits extensive hepatic first-pass metabolism and low aqueous solubility, hence poor oral bioavailability. In this study, beta hydroxypropyl cyclodextrin-FLB inclusion complexes...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghaith, Adel F., Mahrous, Gamal M., Shazly, Gamal A., Zidan, Diaa Eldin Z., Alhamed, Abdullah S., Alqinyah, Mohammed, Almutairi, Mohammed M., Syed, Saeed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609929/
https://www.ncbi.nlm.nih.gov/pubmed/36297875
http://dx.doi.org/10.3390/polym14204298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609929/
https://www.ncbi.nlm.nih.gov/pubmed/36297875
http://dx.doi.org/10.3390/polym14204298

Ejemplares similares